ADVERSE-EFFECTS OF THEOPHYLLINE BETA-AGONIST INTERACTIONS

被引：17

作者：

NICKLAS, RA ^{[1
]}

BALAZS, T ^{[1
]}

机构：

[1] US FDA,DRUG TOX BRANCH,DIV DRUG BIOL,WASHINGTON,DC 20204

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1986年 / 78卷 / 04期

关键词：

D O I：

10.1016/0091-6749(86)90065-5

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：806 / 811

页数：6

共 112 条

[1] INCIDENCE OF CARDIAC-ARRHYTHMIAS IN PATIENTS TAKING SLOW RELEASE SALBUTAMOL AND SLOW RELEASE TERBUTALINE FOR ASTHMA [J].

ALHILLAWI, AH ;

HAYWARD, R ;

JOHNSON, NM .

BRITISH MEDICAL JOURNAL, 1984, 288 (6414) :367-367

[2]

AUSTEN KF, 1975, NEW DIRECTIONS ASTHM, P187

[3]

BAKER BJ, 1984, CLIN PHARMACOL THER, V35, P226

[4]

BALAZS T, 1976, Annals of Clinical and Laboratory Science, V6, P467

[5]

BALAZS T, 1972, RECENT ADV STUDIES C, P770

[6]

BALAZS T, 1981, CARDIAC TOXICOLOGY, P61

[7]

BALAZS T, 1982, CARDIOVASCULAR TOXIC, P199

[8] ARRHYTHMOGENIC EFFECTS OF ORALLY-ADMINISTERED BRONCHODILATORS [J].

BANNER, AS ;

SUNDERRAJAN, EV ;

AGARWAL, MK ;

ADDINGTON, WW .

ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (04) :434-437

[9] THEOPHYLLINE-SALBUTAMOL INTERACTION - BRONCHODILATOR RESPONSE TO SALBUTAMOL AT MAXIMALLY EFFECTIVE PLASMA THEOPHYLLINE CONCENTRATIONS [J].

BARCLAY, J ;

WHITING, B ;

MEREDITH, PA ;

ADDIS, GJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (02) :203-208

[10]

BARKMAN RP, 1981, MED J AUSTRALIA, V1, P316

← 1 2 3 4 5 6 7 8 9 10 →